| 注册
首页|期刊导航|中国食品药品监管|益生菌成品循证研究对提升新质生产力的全球策略启示

益生菌成品循证研究对提升新质生产力的全球策略启示

王强 郭智 向晓晨 沈关心

中国食品药品监管Issue(7):122-133,12.
中国食品药品监管Issue(7):122-133,12.DOI:10.3969/j.issn.1673-5390.2024.07.015

益生菌成品循证研究对提升新质生产力的全球策略启示

The Evidence-Based Research of Probiotic Products:Global Strategy Insights for Enhancing New Quality Productivity

王强 1郭智 2向晓晨 1沈关心3

作者信息

  • 1. 武汉科技大学医学院
  • 2. 华中科技大学协和深圳医院
  • 3. 华中科技大学同济医学院
  • 折叠

摘要

Abstract

The increasing diversity and convenience of health maintenance practices,coupled with growing health consciousness,have driven the functional food industry upwards.Probiotics,as one of the fastest growing segments,have become a focus in the industry.To promote the new quality productivity and healthy development of the probiotics industry,this article focuses on regulatory guidance,industry association promotion,stimulating market potential,creating new scenarios and business models,and addressing consumer demand orientation.It proposes strategies to improve basic research on probiotics,enhance production quality,and strengthen evidence-based research on finished products,aiming to provide references for promoting the high-quality development of China's probiotics industry.

关键词

益生菌/市场潜力/成品循证研究/安全性/临床应用/新质生产力

Key words

probiotics/market potential/evidence-based research on finished products/clinical application/new quality productivity

分类

医药卫生

引用本文复制引用

王强,郭智,向晓晨,沈关心..益生菌成品循证研究对提升新质生产力的全球策略启示[J].中国食品药品监管,2024,(7):122-133,12.

基金项目

武汉亚心总医院科研创新基金重点项目(2022KYCX1-A04) (2022KYCX1-A04)

武汉市武昌医院科研创新基金重点项目(WCYY2022K02) (WCYY2022K02)

中国食品药品监管

1673-5390

访问量0
|
下载量0
段落导航相关论文